Notably, SLC7A11 overexpression is observed in various human cancers, including lymphoma, leukemia, squamous cell carcinoma, breast cancer, glioblastoma, and pancreatic ductal adenocarcinoma (PDAC) [15]. Here, SLC7A11 is linked to breast cancer.